SCHEDULE: Bank of America Discloses RxSight Stake

Bank of America Corporation and its subsidiaries reported a 0.4% beneficial ownership stake in RxSight, Inc. common stock as of June 30, 2025.

Summary

• Bank of America Corporation and its subsidiaries beneficially own 172,091 shares of RxSight, Inc. common stock.
• This ownership represents 0.4% of RxSight, Inc.'s common stock.
• The shares are held in the ordinary course of business and were not acquired for the purpose of changing or influencing control of RxSight, Inc.
• The filing is an Amendment No. 1 to a previous Schedule 13G.
• Bank of America Corporation's beneficial ownership includes shared voting power over 151,216 shares and shared dispositive power over 172,091 shares.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership, providing factual information without indicating positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an institutional investor's passive ownership stake in a publicly traded company, rather than an announcement related to the issuer's operational performance or industry trends.

Key Dates

Keywords

RxSight, Common Stock, Beneficial Ownership, Bank of America, Schedule 13G, Institutional Investor